CCL5 and experimental autoimmune encephalomyelitis: Furthermore, combined neutralization of all three known CCR5 ligands (CCL3, CCL4, CCL5) has been shown to ameliorate the course, i.e., reduce disease activity, in MS animal models of experimental autoimmune encephalomyelitis [43].